Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage
Phase 3 Study of Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage
1 other identifier
interventional
450
1 country
1
Brief Summary
In the aetiology of postpartum uterine atony, hypoxia is considered an important factor although some suggest that peripheral oxygen saturation is not influenced by oxygen inhalation in women during the first and second stages of labor. Enhancing oxygen delivery to myometrium through additional inhaled oxygen may improve uterine contractions. Therefore, it is reasonable to consider that oxygen inhalation may promote myometrial contraction and prevent postpartum haemorrhage (PPH) due to uterine atony. The tendency for the uterus to relax in women encountering respiratory problems immediately after cesarean section under general anaesthesia further strengthened this theory. The aim of this study was to evaluate the effectiveness of oxygen inhalation immediately after vaginal delivery on blood loss. The investigators hypothesized that inhaled oxygen helps to maintain uterine retraction during immediate postpartum period and hence reduces vaginal blood loss.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started May 2010
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 9, 2010
CompletedFirst Posted
Study publicly available on registry
August 12, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2010
CompletedFebruary 14, 2011
May 1, 2010
Same day
August 9, 2010
February 11, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome was the amount of blood loss in the third and fourth stages of labor.
The volume of blood loss was measured by weighing a sheet soaked from the end of the delivery to 2h after birth. Because it is important to collect the blood accurately, we used a specially designed operating sheet and an electronic scale to weigh all the material (with a 1 g deviation range). The quantity of blood (ml) = (weight of used materials - weight of materials prior to use)/1.05. Hemoglobin concentration was estimated on admission and 24 h after delivery
two hours
Secondary Outcomes (1)
incidences of Postpartum Haemorrhage (PPH) (≥500 ml)
two hours
Study Arms (1)
oxygen
EXPERIMENTALInterventions
either 8 L/minute O2 via face mask for 2 hours
Eligibility Criteria
You may qualify if:
- gestational age between 37 and 42 weeks;
- singleton pregnancy;
- live fetus;
- cephalic presentation;
- neonatal birth weight of 2500-4500 g;
- parity between one and five;
- maternal age \< 35 years old;
- vaginal birth
You may not qualify if:
- blood pressure ≥ 140/90mmHg;
- placenta previa;
- placental abruption;
- a history of any bleeding during pregnancy;
- a history of curettage;
- cesarean section or any uterine scar;
- a history of postpartum hemorrhage;
- polyhydramnios;
- signs or symptoms of maternal infection;
- known uterine anomalies;
- history of any drug use during labor;
- abnormal placentation;
- coagulation defects;
- instrumental deliveries;
- hemoglobin concentration \< 8 g/dL;
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bakirkoy Women's and Children's Teaching Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 9, 2010
First Posted
August 12, 2010
Study Start
May 1, 2010
Primary Completion
May 1, 2010
Study Completion
September 1, 2010
Last Updated
February 14, 2011
Record last verified: 2010-05